Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.

@article{Nakashima2013RemissionIP,
  title={Remission in patients with active rheumatoid arthritis by tocilizumab treatment in routine clinical practice: results from 3 years of prospectively registered data.},
  author={Yasuharu Nakashima and Masakazu Kondo and Takaaki Fukuda and Hiroshi Harada and Takahiko Horiuchi and Takashi Ishinishi and Hiroshi Jojima and Koji Kuroda and Hisaaki Miyahara and Masayuki Maekawa and Hiroaki Nishizaka and Ryuji Nagamine and Hitoshi Nakashima and Takeshi Otsuka and Eisuke Shono and Eiichi Suematsu and Takashi Shimauchi and Tomomi Tsuru and Ken Wada and Shigeru Yoshizawa and Seiji Yoshizawa and Yukihide Iwamoto},
  journal={Modern rheumatology},
  year={2013}
}
OBJECTIVES: This study aimed to evaluate the remission in rheumatoid arthritis (RA) patients treated with tocilizumab (TCZ), based on prospectively registered data in clinical practice. METHODS: We studied 114 consecutive RA patients treated with TCZ for an average of 3.5 years. Remission was evaluated by using the EULAR criteria and the new ACR/EULAR Boolean-based criteria. RESULTS: Among 114 patients (average age 52.2 years; average disease duration 10.6 years), 76 (67 %) had previously… CONTINUE READING

From This Paper

Topics from this paper.
8 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-8 of 8 extracted citations

Similar Papers

Loading similar papers…